Label: YVES SAINT LAURENT ALL HOURS FOUNDATION BROAD SPECTRUM SPF 20 SUNSCREEN- octinoxate lotion

  • NDC Code(s): 49967-362-01, 49967-362-02, 49967-362-03, 49967-362-04, view more
    49967-362-05, 49967-362-06, 49967-362-07
  • Packager: L'Oreal USA Products Inc
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated December 24, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient

    Octinoxate 3%

  • Purpose

    Sunscreen

  • Uses

    • helps prevent sunburn
    • if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
  • Warnings

    For external use only

  • Flammable until dry.

    Avoid fire, flame and heat during application.

  • Do not use

    on damaged or broken skin

  • When using this product

    keep out of eyes. Rinse with water to remove.

  • Stop use and ask a doctor if

    rash occurs

  • Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    For sunscreen use:

    • shake well before use
    • apply liberally 15 minutes before sun exposure
    • reapply at least every 2 hours
    • use a water resistant sunscreen if swimming or sweating
    • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including:
    •                 limit time in the sun, especially from 10 a.m. - 2 p.m.
    •                 wear long-sleeved shirts, pants, hats and sunglasses
    • children under 6 months of age: Ask a doctor
  • Other information

    • protect the product in this container from excessive heat and direct sun
  • Inactive ingredients

    water, cyclopentasiloxane, alcohol denat., isododecane, acrylates/polytrimethylsiloxymethacrylate copolymer, butylene glycol, glycerin, polymethylsilsesquioxane, cetyl PEG/PPG-10/1 dimethicone, synthetic fluorphlogopite, isohexadecane, polyglyceryl-4 isostearate, magnesium sulfate, disodium stearoyl glutamate, fragrance, perlite, saccharomyces/xylinum/black tea ferment, silica silylate, aluminum hydroxide, butyrospermum parkii (shea) seedcake extract, hydroxyethylcellulose, BHT, phenoxyethanol, sodium citrate, benzyl alcohol, linalool, citric acid, potassium sorbate, pentaerythrityl tetra-di-t-butyl hydroxyhydrocinnamate, biotin; may contain: titanium dioxide, iron oxides

  • PRINCIPAL DISPLAY PANEL

    image of a carton

    image of a carton
  • INGREDIENTS AND APPEARANCE
    YVES SAINT LAURENT ALL HOURS FOUNDATION BROAD SPECTRUM SPF 20 SUNSCREEN 
    octinoxate lotion
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49967-362
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    Octinoxate (UNII: 4Y5P7MUD51) (Octinoxate - UNII:4Y5P7MUD51) Octinoxate30 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    CYCLOMETHICONE 6 (UNII: XHK3U310BA)  
    ALCOHOL (UNII: 3K9958V90M)  
    ISODODECANE (UNII: A8289P68Y2)  
    BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    POLYMETHYLSILSESQUIOXANE (11 MICRONS) (UNII: Z570VEV8XK)  
    CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2) (UNII: V2W71V8T0X)  
    ISOHEXADECANE (UNII: 918X1OUF1E)  
    POLYGLYCERYL-4 ISOSTEARATE (UNII: 820DPX33S7)  
    MAGNESIUM SULFATE, UNSPECIFIED FORM (UNII: DE08037SAB)  
    DISODIUM STEAROYL GLUTAMATE (UNII: 45ASM2L11M)  
    PERLITE (UNII: 0SG101ZGK9)  
    ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
    HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%) (UNII: R33S7TK2EP)  
    BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
    PHENOXYETHANOL (UNII: HIE492ZZ3T)  
    SODIUM CITRATE (UNII: 1Q73Q2JULR)  
    BENZYL ALCOHOL (UNII: LKG8494WBH)  
    LINALOOL, (+/-)- (UNII: D81QY6I88E)  
    CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
    POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
    PENTAERYTHRITOL TETRAKIS(3-(3,5-DI-TERT-BUTYL-4-HYDROXYPHENYL)PROPIONATE) (UNII: 255PIF62MS)  
    BIOTIN (UNII: 6SO6U10H04)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    FERRIC OXIDE RED (UNII: 1K09F3G675)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:49967-362-011 in 1 CARTON06/01/2017
    125 mL in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:49967-362-02125 mL in 1 BOTTLE; Type 0: Not a Combination Product06/01/201712/30/2024
    3NDC:49967-362-031 in 1 CARTON06/01/201712/30/2024
    310 mL in 1 BOTTLE; Type 0: Not a Combination Product
    4NDC:49967-362-041 in 1 CARTON06/01/201712/30/2024
    45 mL in 1 BOTTLE; Type 0: Not a Combination Product
    5NDC:49967-362-051 mL in 1 PACKET; Type 0: Not a Combination Product06/01/201712/30/2024
    6NDC:49967-362-061.2 mL in 1 BLISTER PACK; Type 0: Not a Combination Product02/08/201912/30/2024
    7NDC:49967-362-071 in 1 CARTON07/30/202012/30/2024
    78 mL in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02006/01/2017
    Labeler - L'Oreal USA Products Inc (002136794)
    Establishment
    NameAddressID/FEIBusiness Operations
    SICOS ET CIE276993581manufacture(49967-362) , pack(49967-362)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!